Bullish
Abivax (ABVX) repurchased $90 million in royalty certificates, paying $45 million in cash and $45 million through a loan convertible to American Depos...
Abivax announced the repurchase of its royalty certificates and the pricing of a $45 million offering of American Depositary Shares (ADS). This news w...
Abivax (ENXTPA:ABVX) is under scrutiny following its Phase 3 trial update for ulcerative colitis, extended cash runway into Q4 2027, and new commercia...
Neutral
Abivax SA Sponsored ADR (NASDAQ:ABVX) experienced a significant 21.6% drop in short interest in April, totaling 2,561,260 shares as of April 15th. The...
Neutral
ABIVAX Société Anonyme has seen a significant 15x surge in its stock price over the last year, despite recent mixed returns. Simply Wall St's analysis...
Abivax announced that its Annual Ordinary and Extraordinary General Meeting will be held on May 11, 2026, at 3:00 p.m. CEST in Paris. The company has ...